2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Gut microbiota implications in Cancer
Cancer is a complex disease that is the world's second biggest cause of mortality. Numerous studies in recent years have underlined the dual significance of the gut microbiota in sustaining the health of the host. The term "gut microbiota" refers to the diverse population of commensal microorganisms, mainly bacteria but also fungi, archaea, and viruses that populate the intestinal tract, particularly the large intestine, and it can be thought of as one factor to which we are constantly exposed, at high doses, throughout our lives. The gastro-intestinal resident bacteria and the human body interact at a sophisticated level in the gut. Gut bacteria can produce a variety of metabolites and bioproducts that help to maintain homeostasis in both the host and the gut.
- Gut Microbiota and Host’s Tumorigenesis
- Microbial biomarkers
- Gut Microbiota and the Inflammasomes
- Faecal Microbiota Transplantation (FMT)
- Probiotics in Cancer
- Bacteria Based Therapies
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Eleni Petsalaki
University of Crete, Greece
Miri Cohen
University of Haifa, IsraelSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China